Abstract
We present the case of a 29.5-year-old girl with Down's syndrome, type 1 diabetes mellitus (DMT1), autoimmune thyroiditis and celiac disease starting on insulin pump therapy. After 22-month follow-up hemoglobin A1c dropped from 9% to 6.8%, even with a lower insulin requirement and no change in BMI.
MeSH terms
-
Adult
-
Blood Glucose / metabolism
-
Diabetes Mellitus, Type 1 / complications*
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Down Syndrome / complications*
-
Female
-
Glycated Hemoglobin / metabolism
-
Hashimoto Disease / complications
-
Humans
-
Hypoglycemic Agents / administration & dosage
-
Hypoglycemic Agents / therapeutic use
-
Insulin / administration & dosage*
-
Insulin / analogs & derivatives
-
Insulin / therapeutic use
-
Insulin Glargine
-
Insulin Infusion Systems*
-
Insulin, Long-Acting
-
Treatment Outcome
Substances
-
Blood Glucose
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
Insulin
-
Insulin, Long-Acting
-
Insulin Glargine